US-based genetics technology corporation Affymetrix agreed on Wednesday to acquire biomedical research company eBioscience for $330m.

The acquisition comes less than a month after eBioscience secured a $45m term loan and a $10m revolving line of credit from GE Capital, Healthcare Financial Services, a corporate venturing fund belonging to energy conglomerate General Electric.

In order to fund the acquisition, GE Capital, Healthcare Financial Services is now acting as the administrative agent for a $190m secured financing commitment enabling Affymetrix…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?